<p>Mean fluorescence intensity (MFI) of CD49d on plasmacytoid dendritic cells (PDCs)(A) and frequency of PDCs expressing CD49d (B), in peripheral blood from untreated MS patients (UNT) and MS patients treated with natalizumab (NTZ) or interferon-β (IFN) determined by flow cytometry. Box-and-whisker plots showing mean, interquartile range, and min-max range. Representative histograms showing CD49d staining on PDCs from an UNT (blue open; C, E) and a NTZ-treated (red filled; D, E) patient.</p
The anti-CD49d monoclonal antibody natalizumab is currently an effective therapy against the relapsi...
<p>p<0.01 is considered statistically significant. Comparisons are pairwise. Bars show mean values, ...
Dimethyl fumarate (DMF) is an immunomodulatory treatment for multiple sclerosis (MS). Despite its wi...
<p>Frequency of plasmacytoid dendritic cells (PDCs) expressing TLR9 (A), HLA-DR (B), and CCR7 (C) in...
<p>Frequency of myeloid and plasmacytoid dendritic cells (MDCs and PDCs) was determined in frozen ce...
Dendritic cells (DCs) serve a critical role both in promoting and inhibiting adaptive immunity. The ...
Dendritic cells (DCs) serve a critical role both in promoting and inhibiting adaptive immunity. The ...
<p>Effects of natalizumab (NTZ) treatment on plasmacytoid dendritic cells (PDCs) stimulated in vitro...
<p>Concentration of CD26 defined CD4<sup>+</sup> T-cell and CD8<sup>+</sup> T-cell subsets in the bl...
Objectives: Dendritic cells (DCs) serve a critical role both in promoting and inhibiting adaptive im...
Myeloid and plasmacytoid dendritic cells (mDCs, pDCs) are central to the initiation and the regulati...
The anti-CD49d monoclonal antibody natalizumab is currently an effective therapy against the relapsi...
<p>(A) Jurkat cells were treated with natalizumab for 24 h and stained for CD49d expression. (B) A p...
Natalizumab is a monoclonal antibody that binds CD49d. Although it is one of the most effective trea...
<p>p<0.01 is considered statistically significant. Comparisons are pairwise. Bars show mean values, ...
The anti-CD49d monoclonal antibody natalizumab is currently an effective therapy against the relapsi...
<p>p<0.01 is considered statistically significant. Comparisons are pairwise. Bars show mean values, ...
Dimethyl fumarate (DMF) is an immunomodulatory treatment for multiple sclerosis (MS). Despite its wi...
<p>Frequency of plasmacytoid dendritic cells (PDCs) expressing TLR9 (A), HLA-DR (B), and CCR7 (C) in...
<p>Frequency of myeloid and plasmacytoid dendritic cells (MDCs and PDCs) was determined in frozen ce...
Dendritic cells (DCs) serve a critical role both in promoting and inhibiting adaptive immunity. The ...
Dendritic cells (DCs) serve a critical role both in promoting and inhibiting adaptive immunity. The ...
<p>Effects of natalizumab (NTZ) treatment on plasmacytoid dendritic cells (PDCs) stimulated in vitro...
<p>Concentration of CD26 defined CD4<sup>+</sup> T-cell and CD8<sup>+</sup> T-cell subsets in the bl...
Objectives: Dendritic cells (DCs) serve a critical role both in promoting and inhibiting adaptive im...
Myeloid and plasmacytoid dendritic cells (mDCs, pDCs) are central to the initiation and the regulati...
The anti-CD49d monoclonal antibody natalizumab is currently an effective therapy against the relapsi...
<p>(A) Jurkat cells were treated with natalizumab for 24 h and stained for CD49d expression. (B) A p...
Natalizumab is a monoclonal antibody that binds CD49d. Although it is one of the most effective trea...
<p>p<0.01 is considered statistically significant. Comparisons are pairwise. Bars show mean values, ...
The anti-CD49d monoclonal antibody natalizumab is currently an effective therapy against the relapsi...
<p>p<0.01 is considered statistically significant. Comparisons are pairwise. Bars show mean values, ...
Dimethyl fumarate (DMF) is an immunomodulatory treatment for multiple sclerosis (MS). Despite its wi...